Global Premature Ejaculation Treatment Market

2016-08-05
Price :
Published : Aug-2016
No. of Pages : 57

Table of Contents

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Vendor segmentation
Key notes
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 06: Geographical segmentation
Market overview
Premature ejaculation treatment market in Americas
Premature ejaculation treatment market in EMEA
Premature ejaculation treatment market in APAC

PART 07: Market segmentation by route of administration
Market overview
Global premature ejaculation treatment market by oral administration
Global premature ejaculation by topical administration market

PART 08: Market segmentation by mechanism of action
Premature ejaculation treatment market by mechanism of action

PART 09: Market segmentation by off-label drugs
Market segmentation by off-label drugs

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape
Competitive scenario
Other prominent vendors

PART 16: Key vendor analysis
Absorption Pharmaceuticals
Allergan
Innovus Pharmaceuticals
Plethora

PART 17: Appendix
List of abbreviations

List of Exhibits

Exhibit 01: Key countries
Exhibit 02: Global premature ejaculation treatment market segmentation: Overview
Exhibit 03: Premature ejaculation prevalence rate for the age group 18-59 by country 2014
Exhibit 04: Premature ejaculation solutions
Exhibit 05: Severity levels of premature ejaculation
Exhibit 06: Clinical diagnosis of premature ejaculation
Exhibit 07: Key product profiles
Exhibit 08: Global premature ejaculation treatment market 2015-2020 ($ billions)
Exhibit 09: Five forces analysis
Exhibit 10: Global premature ejaculation treatment market segmentation by geography 2015-2020
Exhibit 11: Premature ejaculation treatment market in Americas 2015-2020 ($ millions)
Exhibit 12: Types of anxiety affecting adults in US
Exhibit 13: Prevalence rate of premature ejaculation by age group in US
Exhibit 14: Premature ejaculation treatment market in EMEA 2015-2020 ($ millions)
Exhibit 15: Premature ejaculation treatment market in APAC 2015-2020 ($ millions)
Exhibit 16: Number of internet users in APAC countries 2016 (millions)
Exhibit 17: Global premature ejaculation treatment market segmentation by route of administration 2015 and 2020
Exhibit 18: Global premature ejaculation treatment market segmentation by share 2015-2020
Exhibit 19: Global premature ejaculation treatment market by oral administration 2015-2020 ($ billions)
Exhibit 20: Global premature ejaculation treatment market segmentation by topical administration 2015-2020 ($ millions)
Exhibit 21: Market share by mechanism of action 2015-2020
Exhibit 22: Key SSRIs and NSRIs
Exhibit 23: Off-label premature ejaculation drugs market share
Exhibit 24: Impact of drivers
Exhibit 25: Premature ejaculation treatments in pipeline and their side effects
Exhibit 26: Impact of drivers and challenges
Exhibit 27: Internet use by region 2015
Exhibit 28: Absorption: Key takeaways
Exhibit 29: Allergan: Key takeaways
Exhibit 30: Innovus: Key takeaways
Exhibit 31: Plethora: Key takeaways

Filed in: Pharmaceutical, Therapeutics
Publisher : Technavio